Quantitative and Qualitative MRI Assessment of Perivascular Spaces in Parkinson's Disease Patients

Evelina Stagisa1,2, Arturs Silovs1,2,3, Gvido Karlis Skuburs2

  • 1Department of Radiology, Riga East University Hospital, Hipokrata Street 2, LV-1038 Riga, Latvia.

Insights

Parkinson's disease patients show increased enlarged perivascular spaces (ePVS) linked to cognitive decline. MRI-based ePVS quantification may serve as a biomarker for neurodegeneration in PD.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Enlarged perivascular spaces (ePVS) on MRI are linked to cerebral small vessel disease and glymphatic dysfunction.
  • These factors are implicated in the pathophysiology of Parkinson's disease (PD).

Purpose of the Study:

  • To quantify the burden of ePVS in PD patients compared to healthy controls.
  • To investigate the association between ePVS burden and cognitive performance in PD.

Main Methods:

  • 3T MRI with T2-weighted sequences was performed on 42 participants (21 PD patients, 21 controls).
  • ePVS burden was assessed quantitatively (counts) and qualitatively (Potter and Heier scales).
  • Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA).

Main Results:

  • PD patients exhibited significantly higher total ePVS counts in the basal ganglia and centrum semiovale.
  • Higher ePVS burden, particularly largest-per-slice counts, negatively correlated with MoCA scores in PD patients.
  • Qualitative scales showed increased ePVS in PD, with significant differences noted in specific brain regions.

Conclusions:

  • Increased ePVS burden in the basal ganglia and centrum semiovale is associated with cognitive impairment in Parkinson's disease.
  • Quantitative and qualitative ePVS assessment may act as non-invasive imaging biomarkers for neurodegeneration and cognitive decline in PD.
  • Further research with larger cohorts and longitudinal data is recommended to validate prognostic value and develop automated quantification.